FDA Proposes Inspection Of Injectable Products For Visible Particulates

FDA and CDER have released a draft guidance addressing the development and implementation of a holistic, risk-based approach to visible particulate...

Related Keywords

Mark Durivage ,Quality Systems Compliance ,Drug Evaluation ,Biologics Evaluation ,Veterinary Medicine ,Injectable Products ,Visible Particulates ,United States Pharmacopeia ,